cGxP.wire https://validator.w3.org/feed/docs/rss2.html OKYO Pharma Begins Phase 3 NEPTUNE Trial of Urcosimod for Neuropathic Corneal Pain Quoin Pharmaceuticals QRX003 Paper Accepted for Publication Regeneron Presents New Cancer and Cancer-Associated Thrombosis Data at ESMO 2026 Nurix Therapeutics Extends Gilead Oncology Research Collaboration for Two More Years Marea Therapeutics Doses First Patient in Phase 2 Trial of MAR002 for Acromegaly Rani Therapeutics’ RaniPill Platform Accepted into FDA Emerging Technology Program vTv Therapeutics Completes Phase 3 CATT1 Enrollment for Cadisegliatin in Type 1 Diabetes Revolution Medicines Begins Phase 3 RASolute 309 Trial for RAS G12D Pancreatic Cancer Capricor Reports Positive Deramiocel Data in DMD Idorsia Highlights Aprocitentan Data in Obesity and CKM Hypertension Click Therapeutics Gains FDA Clearance for Motivista Smith+Nephew Launches CARTIHEAL AGILI-C in Europe Genmab and AbbVie Report Positive Epcoritamab Phase 3 Results GE HealthCare to Acquire SOFIE in $945M Radiopharma Deal ORIC-259 Advances Toward Clinical Development With Cancer Research UK Equillium Clears Australian Path for EQ504 Phase 1 Trial Korro Doses First Patients in Phase 1/2 Trial of KRRO-121 Curia Invests $28 Million to Expand Sterile API Manufacturing AHN Launches Clinical Trial of Novel PAH Therapy Abbott Gains FDA Approval for New CardioMEMS Capabilities PackGene Advances Scalable AAV Manufacturing Across Capsids GRAIL Presents New Galleri Data at EDCC and ESMO 2026 TuHURA Biosciences Strengthens DOR ADC Platform With U.S. Patent AIRS Medical Gains FDA Clearance for SwiftSight Body Composition Genezen and InterAct Advance AAV8 Therapy for Breast Cancer Consano Bio Raises $15M to Advance C-1101 in Sciatica BlueWhale Bio Advances Synecta Cell Therapy Platform Zydus Launches First Generic Riociguat in the U.S. Pillar Biosciences Launches 80-Gene Myeloid NGS Panel Anixa Reports 90-Day Stable Disease With Ovarian Cancer CAR-T AstraZeneca Completes $2B Investment in Summit Therapeutics Aptar Pharma Launches Premia Precision Quality Standard BridgeBio Pharma Advances BBP-418 in LGMD2I/R9 Crescent Biopharma Gains FDA Clearance for CR-002 IND Pharvaris Real-World HAE Analysis Highlights Treatment Gaps Teva Presents New Ecopipam Data in Tourette Syndrome Stoke Aligns With FDA on Zorevunersen NDA Alterity Presents New ATH434 Phase 2 Data in MSA Rezolute Receives FDA Pre-BLA Recommendation for Ersodetug Sernova and Seraxis Close $11.2M Financing for BetaNova Clear Scientific Reports Positive Phase 2 Results for CS-1103 Resero Bio Advances RNA Liquid Biopsy for Bladder Cancer Aravax to Report PVX108 Phase 2 Peanut Allergy Data CSL and Alentis Partner on Lixudebart for Rare Diseases Vaxcyte Reports Positive Phase 3 VAX-31 Results Orano Med Opens Europe’s First Lead-212 ATLab Surrozen Gains FDA Clearance for SZN-8141 in DME Saros Therapeutics Secures $2M Award for Cancer Immunotherapy Teva Highlights Ecopipam Mechanism in Tourette Syndrome AnnJi Advances AJ201 Into Phase 3 SBMA Trial